Company / Profit Margin
Mirum Pharmaceuticals, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4.5%
FY2025
5-year range
-438.8% / -4.5%
FY2022-FY2025
Trend
+82.8%
vs FY2024
Sector context
#64 of 145
Health Care
What the data says
At -4.5%, Mirum Pharmaceuticals, Inc.'s profit margin ranks #64 of 145 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -438.8% in FY2022 to -4.5% in FY2025.
Based on SEC 10-K filings.
-4.5% in FY2025 with a 3-year CAGR of +434.4%.
Improved from -87.7% to -4.5% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +434.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#64 of 145 in Health CareTop 44% of 145This company -4.5% Sector average -792.7%
▼
+99.4% above sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 82.8% year-over-year.
- Currently 788.2pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.5% | +82.8% |
| FY2024 | -26.1% | +70.2% |
| FY2023 | -87.7% | +80.0% |
| FY2022 | -438.8% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026